US Patent 10106579 Modulation of complement activity
Patent 10106579 was granted and assigned to Ra Pharmaceuticals on October, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10106579 Modulation of complement activity
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.